On Invalid Date, Pulse Biosciences (NASDAQ: PLSE) reported Q4 2023 earnings per share (EPS) of -$0.22, up 0% year over year. Total Pulse Biosciences earnings for the quarter were -$11.93 million. In the same quarter last year, Pulse Biosciences's earnings per share (EPS) was -$0.22.
As of Q2 2024, Pulse Biosciences's earnings has grown year over year. Pulse Biosciences's earnings in the past year totalled -$42.21 million.
What is PLSE's earnings date?
Pulse Biosciences's earnings date is Invalid Date. Add PLSE to your watchlist to be reminded of PLSE's next earnings announcement.
What was PLSE's revenue last quarter?
On Invalid Date, Pulse Biosciences (NASDAQ: PLSE) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Pulse Biosciences's revenue was -$9.00 thousand.
What was PLSE's revenue growth in the past year?
As of Q2 2024, Pulse Biosciences's revenue has grown -100% year over year. This is 107.76 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.76%. Pulse Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.